Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 6, 2009, Pages 510-517

  Tcheurekdjian, Haig ^a,g   Thyne, Shannon M ^a   Williams, L Keoki ^b   Via, Marc ^a,c   Rodriguez Santana, Jose R ^d   Rodriguez Cintron, William ^e   Avila, Pedro C ^f   Burchard, Esteban González ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Centro de Neumologia Pediatrica   (Puerto Rico)

^e VA Caribbean Healthcare System Puerto Rico   (Puerto Rico)

^f NORTHWESTERN UNIVERSITY   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; MONTELUKAST; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DRUG POTENTIATION; DRUG UTILIZATION; ETHNIC DIFFERENCE; FEMALE; FORCED EXPIRATORY VOLUME; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACOGENETICS; PRIORITY JOURNAL; PUERTO RICO; SCHOOL CHILD; SPIROMETRY; TREATMENT RESPONSE;

EID: 67549146647     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60126-3     Document Type: Article

References (29)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention: 2006. Available at: http://www.ginasthma.org. Accessed August 1, 2008.
2. Burchard EG, Avila PC, Nazario S, et al. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med. 2004;169:386-392. (Pubitemid 38134819)
3. US Census Bureau. US Interim Projections by Age, Sex, Race, and Hispanic Origin: 2000-2050. Available at: http://www.census.gov/ipc/www/usinterimproj. Accessed August 21, 2008.
4. Homa DM, Mannino DM, Lara M. Asthma mortality in US Hispanics of Mexican, Puerto Rican, and Cuban heritage, 1990-1995. Am J Respir Crit Care Med. 2000;161:504-509.
5. Lara M, Akinbami L, Flores G, Morgenstern H. Heterogeneity of childhood asthma among Hispanic children: Puerto Rican children bear a disproportionate burden. Pediatrics. 2006;117:43-53. (Pubitemid 46050518)
6. Asthma prevalence and control characteristics by race/ethnicity: United States, 2002. JAMA. 2004;291:1435-1436.
7. Burchard EG, Ziv E, Coyle N, et al. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med. 2003;348:1170-1175. (Pubitemid 36337330)
8. Choudhry S, Ung N, Avila PC, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med. 2005;171:563-570. (Pubitemid 40365410)
9. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med. 2001;344:1351-1357. (Pubitemid 32378389)
10. Yancy CW, Fowler MB, Colucci WS, et al. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure. N Engl J Med. 2001;344:1358-1365. (Pubitemid 32378390)
11. Wright JT Jr, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595-1608. (Pubitemid 40471790)
12. Dries DL, Victor RG, Rame JE, et al. Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation. 2005;112:2403-2410. (Pubitemid 41504489)
13. 2-adrenoceptor function: an in vitro model of asthma. Respir Res. 2006;7:103.
14. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978;118:1-120.
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107-1136.
16. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159:179-187. (Pubitemid 29036522)
17. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics-2002. J Allergy Clin Immunol. 2002;110:S141-S219.
18. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948-968. (Pubitemid 41632054)
19. Wang X, Dockery DW, Wypij D, et al. Pulmonary function growth velocity in children 6 to 18 years of age. Am Rev Respir Dis. 1993;148:1502-1508. (Pubitemid 24002478)
20. Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004;351:1057-1067. (Pubitemid 39167510)
21. Cohen RT, Celedon JC, Hinckson VJ, et al. Health-care use among Puerto Rican and African-American children with asthma. Chest. 2006;130:463-471. (Pubitemid 44267014)
22. Salari K, Choudhry S, Tang H, et al. Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol. 2005;29:76-86. (Pubitemid 40911301)
23. Lara M, Morgenstern H, Duan N, Brook RH. Elevated asthma morbidity in Puerto Rican children: a review of possible risk and prognostic factors. West J Med. 1999;170:75-84. (Pubitemid 29094032)
24. Finkelstein JA, Lozano P, Farber HJ, Miroshnik I, Lieu TA. Underuse of controller medications among Medicaid-insured children with asthma. Arch Pediatr Adolesc Med. 2002;156:562-567. (Pubitemid 34596185)
25. Lieu TA, Lozano P, Finkelstein JA, et al. Racial/ethnic variation in asthma status and management practices among children in managed Medicaid. Pediatrics. 2002;109:857-865. (Pubitemid 34493353)
26. Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162:578-585. (Pubitemid 30647203)
27. Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax. 2003;58:204-210. (Pubitemid 36307997)
28. Phipatanakul W, Greene C, Downes SJ, et al. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann Allergy Asthma Immunol. 2003;91:49-54. (Pubitemid 36909598)
29. Knorr B, Matz J, Bernstein JA, et al; Pediatric Montelukast Study Group. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. JAMA. 1998;279:1181-1186.